Evidence map›Paper›PMID 25923687›Full record

ArticlePLoS pathogens2015

Borna disease virus phosphoprotein impairs the developmental program controlling neurogenesis and reduces human GABAergic neurogenesis.

Chloé Scordel, Alexandra Huttin, Marielle Cochet-Bernoin, Marion Szelechowski, Aurélie Poulet, Jennifer Richardson, Alexandra Benchoua, Daniel Gonzalez-Dunia, Marc Eloit, Muriel Coulpier

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Chloé ScordelINRA, UMR 1161, Maisons-Alfort, France; ANSES, UMR Virologie, Maisons-Alfort, France; Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, UMR Virologie, Maisons-Alfort, France.
Alexandra HuttinINRA, UMR 1161, Maisons-Alfort, France; ANSES, UMR Virologie, Maisons-Alfort, France; Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, UMR Virologie, Maisons-Alfort, France.
Marielle Cochet-BernoinINRA, UMR 1161, Maisons-Alfort, France; ANSES, UMR Virologie, Maisons-Alfort, France; Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, UMR Virologie, Maisons-Alfort, France.
Marion SzelechowskiInstitut National de la Santé et de la Recherche Médicale, UMR 1043, Toulouse, France; Centre National de la Recherche Scientifique, UMR 5282, Toulouse, France; Université Paul Sabatier, Toulouse 3, Toulouse, France.
Aurélie PouletCECS, I-STEM, AFM, Evry, France.
Jennifer RichardsonINRA, UMR 1161, Maisons-Alfort, France; ANSES, UMR Virologie, Maisons-Alfort, France; Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, UMR Virologie, Maisons-Alfort, France.
Alexandra BenchouaCECS, I-STEM, AFM, Evry, France.
Daniel Gonzalez-DuniaInstitut National de la Santé et de la Recherche Médicale, UMR 1043, Toulouse, France; Centre National de la Recherche Scientifique, UMR 5282, Toulouse, France; Université Paul Sabatier, Toulouse 3, Toulouse, France.
Marc EloitUniversité Paris-Est, Ecole Nationale Vétérinaire d'Alfort, UMR Virologie, Maisons-Alfort, France; Pasteur Institute, Pathogen Discovery Laboratory, Biology of Infection Unit, INSERM U1117, Paris, France.
Muriel CoulpierINRA, UMR 1161, Maisons-Alfort, France; ANSES, UMR Virologie, Maisons-Alfort, France; Université Paris-Est, Ecole Nationale Vétérinaire d'Alfort, UMR Virologie, Maisons-Alfort, France.
Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques · FRNeuroDiderot · FRAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRAgence Nationale des Fréquences · FRÉcole Nationale Vétérinaire d'Alfort · FRInserm · FRInstitut Pasteur · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well established that persistent viral infection may impair cellular function of specialized cells without overt damage. This concept, when applied to neurotropic viruses, may help to understand certain neurologic and neuropsychiatric diseases. Borna disease virus (BDV) is an excellent example of a persistent virus that targets the brain, impairs neural functions without cell lysis, and ultimately results in neurobehavioral disturbances. Recently, we have shown that BDV infects human neural progenitor cells (hNPCs) and impairs neurogenesis, revealing a new mechanism by which BDV may interfere with brain function. Here, we sought to identify the viral proteins and molecular pathways that are involved. Using lentiviral vectors for expression of the bdv-p and bdv-x viral genes, we demonstrate that the phosphoprotein P, but not the X protein, diminishes human neurogenesis and, more particularly, GABAergic neurogenesis. We further reveal a decrease in pro-neuronal factors known to be involved in neuronal differentiation (ApoE, Noggin, TH and Scg10/Stathmin2), demonstrating that cellular dysfunction is associated with impairment of specific components of the molecular program that controls neurogenesis. Our findings thus provide the first evidence that a viral protein impairs GABAergic human neurogenesis, a process that is dysregulated in several neuropsychiatric disorders. They improve our understanding of the mechanisms by which a persistent virus may interfere with brain development and function in the adult.

Indexed as

Down-RegulationHost-Pathogen InteractionsNeurogenesisActive Transport, Cell NucleusApolipoproteins EBiomarkersBorna DiseaseBorna disease virusCarrier ProteinsCell ProliferationCells, CulturedFranceGABAergic NeuronsHuman Embryonic Stem CellsHumansMembrane ProteinsApolipoproteins EBiomarkersCarrier ProteinsMembrane ProteinsNerve Tissue ProteinsNoggin ProteinPhosphoproteinsP protein, Borna disease virusRecombinant ProteinsStathminSTMN2 protein, humanTyrosine 3-MonooxygenaseViral Structural Proteins

Identifiers

PMID25923687
PMCPMC4414417
OpenAlexW2003342013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.